SEC Form 4 · accession 0001209191-15-042567
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Gordon Freund
Director
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 11, 2015 | J | 300,000 | $0.00 | D | 590,146 | I | see footnote |
| Common StockF2 | May 11, 2015 | J | 4,493 | $0.00 | A | 4,493 | I | see footnote |
| Common StockF2 | May 11, 2015 | J | 4,493 | $0.00 | D | 0 | I | see footnote |
| Common Stock | May 11, 2015 | J | 3,006 | $0.00 | A | 6,012 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. ("SVP IV") without consideration to its limited and general partners.
- F2The shares are held by SVP IV. John G. Freund, M.D. and Yasunori Kaneko, M.D. are the Managing Members of Skyline Venture Management IV, LLC ("SVM IV"), the general partner of SVP IV, and may be deemed to share voting and dispositive power over the shares held by SVP IV. Stephen Hoffman, M.D., Ph.D. is a member of SVM IV and may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by SVP IV. Dr. Freund disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- F3Represents a pro-rata in-kind distribution by SVM IV without consideration to its members.